Drupal.behaviors.print = function(context) {window.print();window.close();}>

Somalogic Launches Validation Studies of Protein Biomarkers for Pancreatic Cancer and Mesothelioma

October 15, 2010

Somalogic Launches Validation Studies of Protein Biomarkers for Pancreatic Cancer and Mesothelioma

The validation trials will each involve on the order of 400 patients and should be completed within a year, said a company official.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories